Showing 1 - 6 results of 6 for search 'Vicky Ama Moor', query time: 0.03s Refine Results
  1. 1
    Relative adrenal insufficiency in adults with sickle cell disease

    Relative adrenal insufficiency in adults with sickle cell disease by Eugene Sobngwi, Noel Désirée Mbango, Eric Vounsia Balti, Francoise Ngo Sack, Vicky Ama Moor, Jean-Claude Mbanya

    Published 2018-01-01
    Get full text
    Article
  2. 2
    Genetic analysis for rs2280205 (A>G) and rs2276961 (T>C) in SLC2A9 polymorphism for the susceptibility of gout in Cameroonians: a pilot study

    Genetic analysis for rs2280205 (A>G) and rs2276961 (T>C) in SLC2A9 polymorphism for the susceptibility of gout in Cameroonians: a pilot study by Jan René Nkeck, Madeleine Singwé Ngandeu, Vicky Ama Moor, Jériel Pascal Nkeck, Jean-Pierre Chedjou, Aude Laetitia Ndoadoumgue, Wilfred F. Mbacham

    Published 2018-04-01
    Get full text
    Article
  3. 3
    Gut microbiota and kidney function in autosomal dominant polycystic kidney disease participants in Cameroon: a cross-sectional study

    Gut microbiota and kidney function in autosomal dominant polycystic kidney disease participants in Cameroon: a cross-sectional study by Inès Obolo Nwaga, Victorine Bandolo Nzana, Rhoda Nsen Bughe, Isaac Dah, Cheboh Cho-Fon, Maimouna Mahamat, Emmanuelle Ndjong, Aristide Nono, Jean Claude Mballa, Fon Abongwa Acho, Vicky Ama Moor, Wilfred Fon Mbacham, François Folefack Kaze

    Published 2025-01-01
    Get full text
    Article
  4. 4
    Comparative study of the efficacy and tolerability of dihydroartemisinin - piperaquine - trimethoprim <it>versus </it>artemether - lumefantrine in the treatment of uncomplicated <it>Plasmodium falciparum </it>malaria in Cameroon, Ivory Coast and Senegal

    Comparative study of the efficacy and tolerability of dihydroartemisinin - piperaquine - trimethoprim <it>versus </it>artemether - lumefantrine in the treatment of uncomplicated <i... by Yavo William, Tine Rogert, Vicky Ama-Moor, Kuete Thomas, N'diaye Jean-Louis, Kiki Barro Christiane P, Faye Babacar, Oga Agbaya Serge S, Same-Ekobo Albert, Faye Oumar, Menan Hervé, Kane Dieynaba, Kassi Kondo F, Kone Moussa

    Published 2011-07-01
    Get full text
    Article
  5. 5
    HIV-1 residual risk and pre-treatment drug resistance among blood donors: A sentinel surveillance from Gabon

    HIV-1 residual risk and pre-treatment drug resistance among blood donors: A sentinel surveillance from Gabon by Christian Mangala, Désiré Takou, Denis Maulot-Bangola, Grace Beloumou, Olivier Rebienot Pellegrin, Samuel Martin Sosso, Collins Ambe Chenwi, Ezechiel Ngoufack Jagni Semengue, Franck Vigan Codjo, Olga Boussougou, Alex Durand Nka, Michel Tommo, Nadine Fainguem, Rachel Kamgaing, Vicky Ama Moor, Hortense Kamga Gonsu, Veronique Penlap, Thérèse Nkoa, Vittorio Colizzi, Carlo-Federico Perno, Joseph Fokam, Alexis Ndjolo

    Published 2024-01-01
    Get full text
    Article
  6. 6
    HIV-1 residual risk and pre-treatment drug resistance among blood donors: A sentinel surveillance from Gabon.

    HIV-1 residual risk and pre-treatment drug resistance among blood donors: A sentinel surveillance from Gabon. by Christian Mangala, Désiré Takou, Denis Maulot-Bangola, Grace Beloumou, Olivier Rebienot Pellegrin, Samuel Martin Sosso, Collins Ambe Chenwi, Ezechiel Ngoufack Jagni Semengue, Franck Vigan Codjo, Olga Boussougou, Alex Durand Nka, Michel Tommo, Nadine Fainguem, Rachel Kamgaing, Vicky Ama Moor, Hortense Kamga Gonsu, Veronique Penlap, Thérèse Nkoa, Vittorio Colizzi, Carlo-Federico Perno, Joseph Fokam, Alexis Ndjolo

    Published 2024-01-01
    Get full text
    Article

Search Tools: